Hosted on MSN23h
GLP-1 Drugs Cut Risk of Alzheimer's, NVO & LLY Shares Rise
The stock price of the two most prominent players in the diabetes and obesity care market, Novo Nordisk NVO and Eli Lilly LLY ...
Viking Therapeutics: Investors Meeting Reality Of The Obesity Market
Viking Therapeutics, Inc. offers promising advances in obesity and liver diseases, despite a recent stock drop over GLP-1 market concerns. Click for my VKTX update.
Hosted on MSN11h
Butler intends to honor Clowes' history during expansion
Butler University's plans to renovate and expand Clowes Memorial Hall, including the addition of a ballroom space, aim to ...
Pharm Exec4h
The Ups and Downs of AI for Pharma Investors
Ash Shehata from KPMG discusses how artificial technology has a lot to prove, although investors still see a lot of potential in it.
Seeking Alpha23h
LLY Eli Lilly and Company
**NM signifies a non meaningful value. A dash signifies the data is not available.
Healio2h
Adding anthracyclines to taxane-based chemotherapy beneficial in high-risk breast cancer
The addition of anthracyclines to adjuvant taxane-based chemotherapy improved survival for certain high-risk patients with ...